NOVT, CA67000B1040

Argus raises Novanta stock target to USD 157.00

Published on 10/15/2026 at 18:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novanta releases third-quarter results on November 9, 2026. Novanta stock costs EUR 120.50 on October 15, 2026 at 6:40 p.m. CEST, while Nasdaq is down 3.35 percent.

Analyst target and reporting date

  • Argus set a USD 157.00 target for Novanta on October 7, 2026, 15.97 percent above the Nasdaq price.
  • Novanta will release third-quarter results on November 9, 2026, after the U.S. market close.
  • Novanta stock costs EUR 120.50 at Lang & Schwarz on October 15, 2026 at 6:40 p.m. CEST, while Nasdaq trading is down 3.35 percent.
  • Novanta has a USD 5.1 billion market capitalization and a P/E ratio of 86.56.
NOVT, CA67000B1040, Illustration mit AI erstellt.

Argus raised its target for Novanta to USD 157.00 on October 7, 2026, according to Yahoo Finance. The target stood 15.97 percent above the Nasdaq price of USD 135.38, which was down 3.35 percent on October 15, 2026. Novanta stock was trading at EUR 120.50 at Lang & Schwarz on October 15, 2026 at 6:40 p.m. CEST.

November results set the next date

Novanta will release its third-quarter 2026 results after the close of U.S. financial markets on November 9, 2026, and will discuss them on November 10, 2026. The dates came from Business Wire in a release dated October 13, 2026.

Price position spans a wide range

The Nasdaq quote of USD 135.38 was 23.25 percent below Novanta's 52-week high of USD 176.38 and 37.78 percent above its low of USD 98.27. The stock traded at USD 135.38 at 12:49 p.m. ET on October 15, 2026, while the euro quote was EUR 120.50 at Lang & Schwarz later that day.

Novanta's current market picture is still defined by a large valuation spread. Its market capitalization was USD 5.1 billion and its P/E ratio was 86.56 on October 15, 2026. The company is listed on Nasdaq under the ticker NOVT and supplies technology for medical, life science and advanced industrial equipment manufacturers.

Comparison with peers

Novanta: minus 3.35 percent, P/E 86.56, market capitalization USD 5.1 billion.

Coherent (Nasdaq, USD): minus 7.14 percent, P/E 59.64, market capitalization USD 48.2 billion.

Cognex (Nasdaq, USD): minus 3.95 percent, P/E 53.34, market capitalization USD 9.3 billion.

Valuation and dates guide the view

The Argus target gives the stock a dated valuation marker, while the November 9 results date supplies the next company-specific checkpoint. The wide 52-week span also places the current Nasdaq quote materially below its yearly high, even as the target remains above the market price.

Euro quote after the Xetra session

At Lang & Schwarz, Novanta stock was trading at EUR 120.50 on October 15, 2026 at 6:40 p.m. CEST. The Nasdaq quote was USD 135.38 at 12:49 p.m. ET on the same date.

The further course of trading is shown by the continuously updated real-time quote of Novanta stock.

Novanta market data

  • Company: Novanta Inc.
  • ISIN: CA67000B1040
  • Ticker: NOVT
  • Primary exchange: Nasdaq
  • Price Lang & Schwarz (as of October 15, 2026, 6:40 p.m. CEST): EUR 120.50
  • Market capitalization: USD 5.1 billion (as of October 15, 2026)
  • 52-week range: USD 98.27-176.38 (as of October 15, 2026)
  • Sector / Industry: Technology / medical devices
  • Next earnings date: November 9, 2026

Market context: Market report S&P 500.

More news and analyses on Novanta stock

Disclaimer...
en | CA67000B1040 | NOVT | boerse | 70331298 | bgmi